{"SPADE_UN_11336": {"Clinical Information": [{"Medical use": "Wound healing", "Company": "Helix Biomedix(Bothell, Washington, USA)", "Stage of Development": "Preclinical", "Comments": "Wounds treated with HB-107 showed keratinocyte hyperplasia and increased leukocyte infiltration. Furthermore, HB-107 stimulated interleukin-8 secretion from cultured endothelial cells.", "Clinical Trials": []}], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11336", "Peptide Name": "HB-107", "Sequence": "MPKEKVFLKIEKMGRNIRN", "Source": "19-amino-acid fragment of cecropin B", "Target Organism": "No MICs found on DRAMP database", "Reference": ["HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair.WOUND REPAIR AND REGENERATION.2004 MAY-JUN.(PMID:15225214)"], "Biological Activity": ["Unknown"], "Frequent Amino Acids": "KEI", "Absent Amino Acids": "ACDHOQSTUWY", "Basic Residues": 6, "Acidic Residues": 2, "Hydrophobic Residues": 8, "Polar Residues": 9, "Positive Residues": 6, "Negative Residues": 2, "Mass": 2331.85, "PI": 10.45, "Net Charge": 4, "Hydrophobicity": -0.89, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03071", "Similarity": 0.8823529411764706, "Sequence": "KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL"}, {"SPADE_ID": "SPADE_N_05832", "Similarity": 0.8823529411764706, "Sequence": "KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG"}, {"SPADE_ID": "SPADE_N_12482", "Similarity": 0.8823529411764706, "Sequence": "KWKVFKKIEKMGRNIRNGIVK"}]}}}